Illumina applies innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Hitachi and Illumina have collaborated to test the Casava platform against the HDS HNAS platform, providing high performance computing power with outstanding processing power. HDS continues to work with some of the largest genomic sequencing companies coupled with Illumina’s applications.
